Yariv Greenshpan
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Recognition of ErbB Family Dimers by the EGF-like Domain of NRG1alpha and Beta: Implications for Ligand-Based CAR Therapy.
Journal: International journal of molecular sciences
Published: June 08, 2026
Mechanostimulatory Platform for Improved CAR T Cell Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 22, 2024
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 14, 2024
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer.
Journal: Science advances
Published: May 26, 2023
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment.
Journal: International journal of molecular sciences
Published: June 06, 2022
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma.
Journal: International journal of molecular sciences
Published: March 20, 2022
Nanocomposite coatings for the prevention of surface contamination by coronavirus.
Journal: PloS one
Published: November 03, 2021
High throughput screen for the improvement of inducible promoters for tumor microenvironment cues.
Journal: Scientific reports
Published: November 01, 2021
Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic Potencies.
Journal: Molecules (Basel, Switzerland)
Published: September 21, 2020
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity.
Journal: Scientific reports
Published: August 05, 2020
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers.
Journal: Science advances
Published: May 03, 2020
Last Updated: 09/26/2026